Loading...

Ergomed plc

2EM.DE•XETRA
Healthcare
Biotechnology
€11.00
€0.00(0.00%)

Ergomed plc (2EM.DE) Stock Overview

Explore Ergomed plc’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

B

Score: 64.9/100

Key Financials

Market Cap586M
P/E Ratio68.82
EPS (TTM)$0.32
ROE0.20%
Fundamental Analysis

AI Price Forecasts

1 WeekN/A
1 MonthN/A
3 MonthsN/A
1 Year Target$9.92

2EM.DE Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Ergomed plc (2EM.DE) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

Our forecasting models predict significant price movements, with a 12-month target of $9.92.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 68.82 and a market capitalization of 586M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

Frequently Asked Questions

;